This inventor holds 1 USPTO granted patent. Top assignees: Fundacion De Investigacion Hm Hospitales, Medcom Advance, S.a., Medcom Tech, S.a.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Manuel Garcia Algar: Innovator in Tumor Cell Detection
Introduction
Manuel Garcia Algar is a notable inventor based in Tarragona, Spain. He has made significant contributions to the field of medical technology, particularly in the detection of tumor cells. His innovative approach has the potential to enhance cancer diagnostics and treatment.
Latest Patents
Garcia Algar holds a patent for an "Apparatus and method for detection of tumour cells and circulating tumour cells." This invention relates to a method of detecting and quantifying the number of circulating tumor cells (CTCs) and/or tumor cells (TCs) from a liquid biopsy. The process utilizes a hyperoxic environment and incubation with a fluorophore-labelled metabolic indicator, specifically a fluorophore-labelled 2-D-glucose derivative, along with microfluidic chips. This patent showcases his commitment to advancing cancer detection technologies.
Career Highlights
Throughout his career, Manuel Garcia Algar has worked with prominent organizations, including Fundación de Investigación HM Hospitales and Medcom Tech, S.A. His experience in these institutions has allowed him to develop and refine his innovative ideas in medical technology.
Collaborations
Garcia Algar has collaborated with talented individuals such as Carlos Villanueva Leal and Sara Gomez De Pedro. These partnerships have contributed to the advancement of his research and the successful development of his inventions.
Conclusion
Manuel Garcia Algar is a pioneering inventor whose work in tumor cell detection is making a significant impact in the medical field. His innovative methods and collaborations highlight the importance of research and development in improving cancer diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile